LDLR and infection: However, when HepG2 cells were treated with monoclonal antibodies against both LDLR and low-density lipoprotein receptor-related protein (LRP) infection of HepG2 cells by CS8-LV-shIDOL was completely blocked (Figures 8A–8C).